secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2024-09-19T23:59:59+00:00
Accession:  0001104659-24-101327
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Board member Dr. Brian Kotzin resigns from Rigel board effective Sept. 16, 2024
-------------------------------------------------------------------------------

- Dr. Brian Kotzin resigned as independent director and from all committees, effective September 16, 2024.
- Resignation not due to any disagreement with Rigel's operations, policies, or practices.
- Kotzin chaired the Scientific and Clinical Trial Advisory Committee and served on the Corporate Governance, Healthcare Compliance, and Nominating committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000110465924101327/0001104659-24-101327-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000110465924101327/tm2424205d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-101327

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer